Ellington Management Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-3,000
| Closed | -$266K | – | 499 |
|
|
2019
Q4 | $266K | Sell |
3,000
-12,000
| -80% | -$1.06M | 0.06% | 326 |
|
|
2019
Q3 | $1.14M | Sell |
15,000
-100
| -0.7% | -$7.57K | 0.21% | 80 |
|
|
2019
Q2 | $1.1M | Buy |
+15,100
| New | +$1.1M | 0.19% | 108 |
|
|
2019
Q1 | – | Sell |
-4,800
| Closed | -$443K | – | 528 |
|
|
2018
Q4 | $443K | Buy |
+4,800
| New | +$443K | 0.13% | 156 |
|
|
2018
Q2 | – | Sell |
-12,900
| Closed | -$1.22M | – | 464 |
|
|
2018
Q1 | $1.22M | Buy |
12,900
+1,800
| +16% | +$170K | 0.09% | 132 |
|
|
2017
Q4 | $1.07M | Buy |
+11,100
| New | +$1.07M | 0.18% | 69 |
|
|
2017
Q3 | – | Sell |
-5,800
| Closed | -$421K | – | 595 |
|
|
2017
Q2 | $421K | Buy |
5,800
+1,900
| +49% | +$138K | 0.06% | 293 |
|
|
2017
Q1 | $254K | Buy |
+3,900
| New | +$254K | 0.01% | 497 |
|
|
2016
Q4 | – | Sell |
-12,000
| Closed | -$757K | – | 508 |
|
|
2016
Q3 | $757K | Buy |
+12,000
| New | +$757K | 0.21% | 139 |
|
|
2015
Q4 | – | Sell |
-8,535
| Closed | -$464K | – | 560 |
|
|
2015
Q3 | $464K | Sell |
8,535
-7,365
| -46% | -$400K | 0.13% | 245 |
|
|
2015
Q2 | $1.07M | Sell |
15,900
-900
| -5% | -$60.5K | 0.26% | 90 |
|
|
2015
Q1 | $983K | Buy |
+16,800
| New | +$983K | 0.2% | 129 |
|